Unknown

Dataset Information

0

A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.


ABSTRACT: Hypoxia is a characteristic of solid tumors especially Glioblastoma and is critical to chemoresistance. Cancer stem cells present in hypoxic niches are known to be a major cause of the progression, metastasis and relapse. We tried to identify synergistic combinations of drugs effective in both hypoxia and normoxia in tumor cells as well as in cancer stem cells. Since COX-2 is over-expressed in subset of glioblastoma and is also induced in hypoxia, we studied combinations of a prototype Cyclooxygenase (COX-2) inhibitor, NS-398 with various drugs (BCNU, Temozolomide, 2-Deoxy-D-glucose and Cisplatin) for their ability to abrogate chemoresistance under both severe hypoxia (0.2% O2) and normoxia (20% O2) in glioma cells. The only effective combination was of NS-398 and BCNU which showed a synergistic effect in both hypoxia and normoxia. This synergism was evident at sub-lethal doses for either of the single agent. The effectiveness of the combination resulted from increased pro- apoptotic and decreased anti-apoptotic molecules and increased caspase activity. PGE2 levels, a manifestation of COX-2 activity were increased during hypoxia, but were reduced by the combination during both hypoxia and normoxia. The combination reduced the levels of epithelial-mesenchymal transition (EMT) markers. It also resulted in a greater reduction of cell migration. While single drugs could reduce the number of gliomaspheres, the combination successfully abrogated their formation. The combination also resulted in a greater reduction of the cancer stem cell marker CD133. This combination could be a prototype of possible therapy in a tumor with a high degree of hypoxia like glioma.

SUBMITTER: Jalota A 

PROVIDER: S-EPMC5915077 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.

Jalota Akansha A   Kumar Mukesh M   Das Bhudev C BC   Yadav Ajay K AK   Chosdol Kunzang K   Sinha Subrata S  

Oncotarget 20180406 26


Hypoxia is a characteristic of solid tumors especially Glioblastoma and is critical to chemoresistance. Cancer stem cells present in hypoxic niches are known to be a major cause of the progression, metastasis and relapse. We tried to identify synergistic combinations of drugs effective in both hypoxia and normoxia in tumor cells as well as in cancer stem cells. Since COX-2 is over-expressed in subset of glioblastoma and is also induced in hypoxia, we studied combinations of a prototype Cyclooxyg  ...[more]

Similar Datasets

| S-EPMC6883317 | biostudies-literature
| S-EPMC6664066 | biostudies-literature
| S-EPMC8110964 | biostudies-literature
| S-EPMC3519606 | biostudies-literature
| S-EPMC4210185 | biostudies-literature
| S-EPMC6263055 | biostudies-literature
| S-EPMC8472328 | biostudies-literature